DetectaChem/MD-Bio Introduce Assay for Monkeypox Detection

DetectaChem and its subsidiary MD-Bio, the global leaders in innovative threat detection solutions used extensively by the U.S. Department of Defense, U.S. Homeland Security, law enforcement, first responders and public health agencies around the world, today announce the launch of their MD-Bio qPCR Monkeypox Detection Assay.

As the global need for monkeypox testing solutions rapidly grows, the MD-Bio qPCR Monkeypox Detection Assay will give testing centers the ability to quickly and accurately screen for active monkeypox infections using their own PCR machines.

The MD-Bio qPCR Monkeypox Detection Assay works by detecting active infections through targeting the hemagglutinin gene found in the virus.

"In the U.S. and around the world, we are seeing cases sharply rising and in response we have worked to launch a viable testing assay solution," says DetectaChem and MD-Bio COO, Travis Kisner. "This new assay will help our testing centers and communities prepare for any surges in monkeypox cases or testing needs."

The MD-Bio qPCR Monkeypox Assay is available for purchase now and is for research purposes only. For more information, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.

Our Current Sponsors